Bertrand C. Liang

Bertrand C.
Liang was the founder of TRACON Pharmaceuticals, Inc. (founded in 2005) where he served as Chairman from 2005 to 2010, and Pfenex, Inc. (founded in 2009) where he held the position of President, CEO, Secretary & Class III Director from 2015 to 2017.
Dr. Liang is also the founder of Fortress Biotech, Inc. Dr. Liang's current jobs include Director at Asphelia Pharmaceuticals, Inc., Director at Balboa Biosciences, Inc., Managing Director & Executive Director at LCC Ventures (since 2014), Director at Pico Pharmaceuticals, Inc., and Chief Medical Officer at Purple Biotech Ltd.
(since 2020).
Dr. Liang's former jobs include Vice Chairman at Paramount BioCapital Asset Management, Inc., Vice Chairman at Paramount BioSciences LLC, Director at La Jolla Pharmaceutical Co. (2010-2012), Director at TRF Pharma, Inc., Global Development Leader at Amgen, Inc., Principal at Biogen MA, Inc., Vice President at Biogen, Inc., Vice President, Head-Hematology & Oncology at IDEC Corp., and Principal at The University of Colorado, the University of Vermont, and the National Cancer Institute.
Dr. Liang's education includes an undergraduate degree from Boston University, an MBA from Regis University, a doctorate from The University of Bolton, and a doctorate from Feinberg School of Medicine.
Dr. Liang is also the founder of Fortress Biotech, Inc...